CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents. - Reuvekamp T; Ngai LL; den Hartog D; Carbaat-Ham J; Fayed MMHE; Scholten WJ; Mocking TR; Chitu DA; Pabst T; Klein SK; Stussi G; Griskevicius L; et al. (Leukemia, 2025)